Open in App
  • Local
  • U.S.
  • Election
  • Politics
  • Crime
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • SurvivorNet

    The Drug Tevimbra Now Approved For Use in Esophageal Cancer– Finally Some Help For Patients In Great Need

    By SurvivorNet Staff,

    2024-05-20

    https://img.particlenews.com/image.php?url=39O4YV_0tBo8RDn00

    The Food and Drug Administration (FDA has just approved tislelizumab-jsgr (Tevimbra) for use in adult patients with unresectable or metastatic squamous cell cancer of the esophagus. The drug has been approved as a second-line monotherapy and comes from the company BeiGene.

    Expand All
    Comments / 0
    Add a Comment
    YOU MAY ALSO LIKE
    Most Popular newsMost Popular

    Comments / 0